Stephen H. Willard
2022
In 2022, Stephen H. Willard earned a total compensation of $799.9K as Chief Executive Officer at NRX Pharmaceuticals.
Compensation breakdown
| Salary | $233,871 |
|---|---|
| Stock Awards | $566,000 |
| Total | $799,871 |
Willard received $566K in stock awards, accounting for 71% of the total pay in 2022.
Willard also received $233.9K in salary.
Rankings
In 2022, Stephen H. Willard's compensation ranked 3,503rd out of 5,756 executives tracked by ExecPay. In other words, Willard earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,503 out of 5,756 | 39th |
Division Manufacturing | 1,988 out of 3,133 | 37th |
Major group Chemicals And Allied Products | 950 out of 1,419 | 33rd |
Industry group Drugs | 889 out of 1,320 | 33rd |
Industry Pharmaceutical Preparations | 649 out of 966 | 33rd |
Source: SEC filing on November 22, 2023.
Willard's colleagues
We found six more compensation records of executives who worked with Stephen H. Willard at NRX Pharmaceuticals in 2022.
2022
Ira Strassberg
NRX Pharmaceuticals
Chief Financial Officer
2022
Jonathan Javitt
NRX Pharmaceuticals
Chief Executive Officer
2022
Robert Besthof
NRX Pharmaceuticals
Chief Executive Officer
2022
Alessandra Daigneault
NRX Pharmaceuticals
General Counsel
2022
Seth Van Voorhees
NRX Pharmaceuticals
Chief Financial Officer
2022
Riccardo Panicucci
NRX Pharmaceuticals